Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Addington

Showing results (101-110 of 400) with videos related to

Pageof 40
Sort By:
Schizophrenia Research|March 14, 2017
Testing the feasibility of a computerized facial affect recognition training in early psychosisMariapaola Barbato, Lisa Buchy, Signe Bray, et al.
General Hospital Psychiatry|April 23, 2020
A mobile-based app to monitor social functioning among youth at-risk for psychosis: Single-arm feasibility and acceptability studyOlga Santesteban-Echarri, Jacky Tang, Mohammed K Shakeel, et al.
Schizophrenia Bulletin|June 15, 2007
Biological, life course, and cross-cultural studies all point toward the value of dimensional and developmental ratings in the classification of psychosisRina Dutta, Talya Greene, Jean Addington, et al.
Schizophrenia Research|September 24, 2013
Theory of mind and social judgments in people at clinical high risk of psychosisKristin M Healey, David L Penn, Diana Perkins, et al.
Early Intervention in Psychiatry|February 9, 2024
Negative self-reference as a component of subthreshold psychotic symptoms in clinical high-risk youthMichelle Sloan, Rebecca Sturner, Jean Addington, et al.
Early Intervention in Psychiatry|September 29, 2011
Treating young individuals at clinical high risk for psychosisCatherine Marshall, Jean Addington, Irvin Epstein, et al.
Journal of Psychiatry & Neuroscience : JPN|September 27, 2012
Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive taskIvonne Suridjan, Pablo Rusjan, Jean Addington, et al.
Psychiatry Research|March 12, 2014
Development and preliminary validation of the First Episode Social Functioning Scale for early psychosisTania Lecomte, Marc Corbière, Tom Ehmann, et al.
Schizophrenia Research|October 15, 2014
Movement abnormalities predict transitioning to psychosis in individuals at clinical high risk for psychosisDallas A Callaway, Diana O Perkins, Scott W Woods, et al.
Journal of Clinical Psychopharmacology|January 19, 2002
Double-blind, placebo-controlled comparison of the efficacy of sertraline as treatment for a major depressive episode in patients with remitted schizophreniaDonald Addington, Jean Addington, Scott Patten, et al.
Pageof 40

Showing results (101-110 of 400) with videos related to

Sort By:
Pageof 40
Schizophrenia Research|March 14, 2017
Testing the feasibility of a computerized facial affect recognition training in early psychosisMariapaola Barbato, Lisa Buchy, Signe Bray, et al.
General Hospital Psychiatry|April 23, 2020
A mobile-based app to monitor social functioning among youth at-risk for psychosis: Single-arm feasibility and acceptability studyOlga Santesteban-Echarri, Jacky Tang, Mohammed K Shakeel, et al.
Schizophrenia Bulletin|June 15, 2007
Biological, life course, and cross-cultural studies all point toward the value of dimensional and developmental ratings in the classification of psychosisRina Dutta, Talya Greene, Jean Addington, et al.
Schizophrenia Research|September 24, 2013
Theory of mind and social judgments in people at clinical high risk of psychosisKristin M Healey, David L Penn, Diana Perkins, et al.
Early Intervention in Psychiatry|February 9, 2024
Negative self-reference as a component of subthreshold psychotic symptoms in clinical high-risk youthMichelle Sloan, Rebecca Sturner, Jean Addington, et al.
Early Intervention in Psychiatry|September 29, 2011
Treating young individuals at clinical high risk for psychosisCatherine Marshall, Jean Addington, Irvin Epstein, et al.
Journal of Psychiatry & Neuroscience : JPN|September 27, 2012
Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive taskIvonne Suridjan, Pablo Rusjan, Jean Addington, et al.
Psychiatry Research|March 12, 2014
Development and preliminary validation of the First Episode Social Functioning Scale for early psychosisTania Lecomte, Marc Corbière, Tom Ehmann, et al.
Schizophrenia Research|October 15, 2014
Movement abnormalities predict transitioning to psychosis in individuals at clinical high risk for psychosisDallas A Callaway, Diana O Perkins, Scott W Woods, et al.
Journal of Clinical Psychopharmacology|January 19, 2002
Double-blind, placebo-controlled comparison of the efficacy of sertraline as treatment for a major depressive episode in patients with remitted schizophreniaDonald Addington, Jean Addington, Scott Patten, et al.
Pageof 40